Control and Elimination of Extensively Drug-Resistant Acinetobacter baumanii in an Intensive Care Unit
We decreased antimicrobial drug consumption in an intensive care unit in Lebanon by changing to colistin monotherapy for extensively drug-resistant Acinetobacter baumanii infections. We saw a 78% decrease of A. baumanii in sputum and near-elimination of blaoxa-23-carrying sequence type 2 clone over...
Main Authors: | Amanda Chamieh, Tania Dagher Nawfal, Tala Ballouz, Claude Afif, George Juvelekian, Sani Hlais, Jean-Marc Rolain, Eid Azar |
---|---|
Format: | Article |
Language: | English |
Published: |
Centers for Disease Control and Prevention
2019-10-01
|
Series: | Emerging Infectious Diseases |
Subjects: | |
Online Access: | https://wwwnc.cdc.gov/eid/article/25/10/18-1626_article |
Similar Items
-
Antimicrobial susceptibility patterns of Acinetobacter baumanii isolates from ICU and non-ICU wards
by: Nyoman Sri Budayanti, et al.
Published: (2019-01-01) -
Physician’s dilemma in treating Acinetobacter baumanii: A combination of art and science
by: Sagar Khadanga
Published: (2014-10-01) -
Phenotypic and genotypic detection of metallo-β-lactamases in A. baumanii isolates obtained from clinical samples in Shahrekord, southwest Iran
by: Mansoor Khaledi, et al.
Published: (2019-09-01) -
Risk factors and outcome associated with coinfection with carbapenem-resistant Klebsiella pneumoniae and carbapenem-resistant Pseudomonas aeruginosa or Acinetobacter baumanii: a descriptive analysis
by: Anthony Sophonsri, et al.
Published: (2023-10-01) -
Association of Single Nucleotide Polymorphisms in Toll-like Receptors with Acinetobacter baumanii Infectionin a Chinese Population
by: Lei HE, et al.
Published: (2016-02-01)